PT93876A - Processo para a preparacao de poliaminas e de polipeptideos uteis como antagonistas de neurotransmissores de aminoacidos excitadores e/ou como bloqueadores de canais de calcio - Google Patents

Processo para a preparacao de poliaminas e de polipeptideos uteis como antagonistas de neurotransmissores de aminoacidos excitadores e/ou como bloqueadores de canais de calcio

Info

Publication number
PT93876A
PT93876A PT93876A PT9387690A PT93876A PT 93876 A PT93876 A PT 93876A PT 93876 A PT93876 A PT 93876A PT 9387690 A PT9387690 A PT 9387690A PT 93876 A PT93876 A PT 93876A
Authority
PT
Portugal
Prior art keywords
calcium channels
useful
polipeptidees
neurotransmitters
blockers
Prior art date
Application number
PT93876A
Other languages
English (en)
Other versions
PT93876B (pt
Inventor
Nicholas Alex Saccomano
Robert A Volkmann
Original Assignee
Pfizer
Natural Product Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer, Natural Product Sciences Inc filed Critical Pfizer
Publication of PT93876A publication Critical patent/PT93876A/pt
Publication of PT93876B publication Critical patent/PT93876B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00—Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08—Hydroxylamino compounds or their ethers or esters
    • C07C239/16—Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43518—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from spiders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Insects & Arthropods (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Reproductive Health (AREA)
  • Vascular Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
PT93876A 1989-04-28 1990-04-26 Processo para a preparacao de poliaminas e de polipeptideos uteis como antagonistas de neurotransmissores de aminoacidos excitadores e/ou como bloqueadores de canais de calcio PT93876B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34618189A 1989-04-28 1989-04-28

Publications (2)

Publication Number Publication Date
PT93876A true PT93876A (pt) 1990-11-20
PT93876B PT93876B (pt) 1996-09-30

Family

ID=23358305

Family Applications (1)

Application Number Title Priority Date Filing Date
PT93876A PT93876B (pt) 1989-04-28 1990-04-26 Processo para a preparacao de poliaminas e de polipeptideos uteis como antagonistas de neurotransmissores de aminoacidos excitadores e/ou como bloqueadores de canais de calcio

Country Status (25)

Country Link
EP (2) EP0395357B1 (pt)
JP (8) JPH0774187B2 (pt)
KR (2) KR920007554B1 (pt)
CN (2) CN1038931C (pt)
AT (1) ATE131813T1 (pt)
AU (1) AU615144B2 (pt)
CA (2) CA2015505C (pt)
CZ (1) CZ283830B6 (pt)
DD (2) DD298412A5 (pt)
DE (1) DE69024253T2 (pt)
DK (1) DK0395357T3 (pt)
EG (1) EG19311A (pt)
ES (1) ES2081929T3 (pt)
FI (1) FI902139A7 (pt)
GR (1) GR3018976T3 (pt)
HU (1) HU223593B1 (pt)
IE (2) IE69848B1 (pt)
IL (3) IL94147A (pt)
NO (1) NO300128B1 (pt)
NZ (2) NZ233469A (pt)
PL (1) PL165148B1 (pt)
PT (1) PT93876B (pt)
RU (1) RU2037498C1 (pt)
YU (1) YU84590A (pt)
ZA (1) ZA903229B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5122596A (en) * 1989-09-29 1992-06-16 Pfizer Inc. Polypeptides useful as blockers of calcium channels
US5037846A (en) * 1990-01-02 1991-08-06 Pfizer Inc. Indolyl-3 polyamines and their use as antagonists of excitatory amino acid neurotransmitters
US5312928A (en) * 1991-02-11 1994-05-17 Cambridge Neuroscience Calcium channel antagonists and methodology for their identification
US5461032A (en) * 1991-03-01 1995-10-24 Fmc Corporation Insecticidally effective peptides
US6011068A (en) * 1991-08-23 2000-01-04 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
DE69233586T2 (de) * 1991-08-23 2006-09-28 NPS Pharmaceuticals, Inc., Salt Lake City Kalzium-Rezeptor aktive Verbindungen
US5858684A (en) * 1991-08-23 1999-01-12 The Brigham And Women's Hospital, Inc. Method of screening calcium receptor-active molecules
US5185369A (en) * 1991-08-23 1993-02-09 Pfizer Inc. Synthetic heteroaryl polyamines as excitatory amino acid neurotransmitter antagonists
US5763569A (en) * 1991-08-23 1998-06-09 The Brigham And Women's Hospital, Inc Calcium receptor-active molecules
US6313146B1 (en) 1991-08-23 2001-11-06 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US5688938A (en) * 1991-08-23 1997-11-18 The Brigham & Women's Hospital, Inc. Calcium receptor-active molecules
US6031003A (en) * 1991-08-23 2000-02-29 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
US6001884A (en) * 1991-08-23 1999-12-14 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
IL104419A0 (en) * 1992-01-24 1993-05-13 Fmc Corp Insecticidally effective peptides
US5763568A (en) * 1992-01-31 1998-06-09 Zeneca Limited Insecticidal toxins derived from funnel web (atrax or hadronyche) spiders
US5962314A (en) * 1993-02-23 1999-10-05 Nps Pharmaceuticals, Inc. Calcium receptor-active molecules
AU3777093A (en) * 1993-02-23 1994-09-14 Brigham And Women's Hospital Calcium receptor-active molecules
US5457178A (en) * 1993-07-07 1995-10-10 Fmc Corporation Insecticidally effective spider toxin
JPH09505058A (ja) * 1993-11-15 1997-05-20 ベイカー・メディカル・リサーチ・インスティテュート 心機能不全の治療方法およびそのために有用な医薬組成物
EP1275635A1 (en) 1994-10-21 2003-01-15 Nps Pharmaceuticals, Inc. Calcium receptor-active compounds
US5869602A (en) * 1995-03-17 1999-02-09 Novo Nordisk A/S Peptide derivatives
US5756459A (en) * 1995-06-07 1998-05-26 Fmc Corporation Insecticidally effective peptides isolatable from phidippus spider venom
US6271196B1 (en) * 1996-03-05 2001-08-07 Regents Of The University Of Ca Methods of alleviating neuropathic pain using prosaposin-derived peptides
JP4117506B2 (ja) * 1996-05-01 2008-07-16 エヌピーエス ファーマシューティカルズ インコーポレイテッド 無機イオン活性化合物
AUPO733397A0 (en) * 1997-06-13 1997-07-10 University Of Sydney, The Pesticidal compounds
CN1071115C (zh) * 1998-08-07 2001-09-19 彭小平 一种治疗胃肠炎及溃疡的复方药
FR2802817B1 (fr) * 1999-12-23 2002-10-11 Centre Nat Rech Scient Nouveaux inhibiteurs de glycosidases et leurs applications pharmacologiques, notamment pour traiter le diabete
WO2001070773A2 (en) * 2000-03-22 2001-09-27 Basf Ag Insecticidal peptides and methods for using same
FR2820136A1 (fr) * 2001-01-26 2002-08-02 Aventis Pharma Sa Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
FR2885129B1 (fr) 2005-04-29 2007-06-15 Proskelia Sas Nouveaux derives de l'ureee substituee parun thiazole ou benzothiazole, leur procede de preparation, leur application a titre de medicaments, les compositions pharmaceutiques les renfermant et utilisation.
CN108949771B (zh) * 2018-08-02 2021-10-19 南京农业大学 拟环纹豹蛛c家族杀虫基因及其编码的成熟肽与应用
EP4390515A1 (en) 2022-12-22 2024-06-26 Carl Zeiss Vision International GmbH Spectacle lens and method for generating design data for a spectacle lens

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950739A (en) * 1988-02-10 1990-08-21 New York University Membrane calcium channels and factors and methods for blocking, isolating and purifying calcium channels
GB8820442D0 (en) * 1988-08-30 1988-09-28 Usherwood P N R Therapeutic polyamine amides

Also Published As

Publication number Publication date
DD293959A5 (de) 1991-09-19
ATE131813T1 (de) 1996-01-15
CN1038931C (zh) 1998-07-01
NO901881D0 (no) 1990-04-27
YU84590A (sh) 1992-09-07
IL112522A (en) 2005-12-18
CS215790A3 (en) 1992-02-19
JP2747279B2 (ja) 1998-05-06
IE901496L (en) 1990-10-28
JPH09118693A (ja) 1997-05-06
KR920007554B1 (ko) 1992-09-07
ZA903229B (en) 1991-12-24
CA2194103C (en) 2000-01-04
JPH07165793A (ja) 1995-06-27
ES2081929T3 (es) 1996-03-16
AU5453590A (en) 1990-11-08
CZ283830B6 (cs) 1998-06-17
JPH09118692A (ja) 1997-05-06
CN1136960A (zh) 1996-12-04
JP2746361B2 (ja) 1998-05-06
DE69024253D1 (de) 1996-02-01
EP0395357A2 (en) 1990-10-31
IL112522A0 (en) 1995-05-26
HU223593B1 (hu) 2004-09-28
AU615144B2 (en) 1991-09-19
GR3018976T3 (en) 1996-05-31
EP0696578A3 (en) 1998-04-29
RU2037498C1 (ru) 1995-06-19
JP2744904B2 (ja) 1998-04-28
CA2015505A1 (en) 1990-10-28
KR930000163B1 (ko) 1993-01-11
IL94147A0 (en) 1991-01-31
NZ244480A (pt) 1994-12-22
CN1047078A (zh) 1990-11-21
EG19311A (en) 1995-02-28
EP0395357A3 (en) 1992-04-01
PL165148B1 (en) 1994-11-30
KR900015745A (ko) 1990-11-10
JP2691141B2 (ja) 1997-12-17
JP2746360B2 (ja) 1998-05-06
JPH09118694A (ja) 1997-05-06
PT93876B (pt) 1996-09-30
JPH0774187B2 (ja) 1995-08-09
CA2015505C (en) 1997-03-11
JPH09118690A (ja) 1997-05-06
IE950345L (en) 1990-10-28
EP0395357B1 (en) 1995-12-20
JP2746359B2 (ja) 1998-05-06
NZ233469A (pt) 1994-12-22
JPH09118691A (ja) 1997-05-06
FI902139A7 (fi) 1990-10-29
HU902610D0 (en) 1990-09-28
DD298412A5 (de) 1992-02-20
CA2194103A1 (en) 1990-10-29
DE69024253T2 (de) 1996-05-15
JPH09132596A (ja) 1997-05-20
IL94147A (en) 1998-10-30
EP0696578A2 (en) 1996-02-14
NO300128B1 (no) 1997-04-14
FI902139A0 (fi) 1990-04-27
JPH0314551A (ja) 1991-01-23
IE69848B1 (en) 1996-10-02
HUT55415A (en) 1991-05-28
DK0395357T3 (da) 1996-01-29
NO901881L (no) 1990-10-29

Similar Documents

Publication Publication Date Title
EG19311A (en) Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels.
PT95424A (pt) Processo para a preparacao de polipeptideos uteis como bloqueadores de canais de calcio
DK140996A (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetraflour-6-alkyl-benzoesyreforbindelser
DE69329884D1 (de) Verfahren zur Bekämpfung von Schadinsekten
MX9304497A (es) Polipeptido de la agelenopsis aperta bloqueante de los canales de calcio.
MX9302925A (es) Polipeptidos de bloqueo de canales del calcio a partir de filistata hibernalis.
ATE48531T1 (de) Verfahren zum sterilisieren von rekombinantem mikroorganismus.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960628

NF3A Restitutio in integrum

Free format text: 20020315 RESTITUTIO IN INTEGRUM

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20091228